Last 90.10 INR
Change Today -1.40 / -1.53%
Volume 133.9K
FDCLT On Other Exchanges
Symbol
Exchange
Natl India
As of 5:44 AM 05/21/13 All times are local (Market data is delayed by at least 15 minutes).

fdc ltd (FDCLT) Snapshot

Open
90.55
Previous Close
91.50
Day High
92.50
Day Low
90.10
52 Week High
12/24/12 - 105.95
52 Week Low
06/1/12 - 75.50
Market Cap
16.3B
Average Volume 10 Days
146.4K
EPS TTM
7.30
Shares Outstanding
181.2M
EX-Date
08/6/12
P/E TM
12.3x
Dividend
2.00
Dividend Yield
2.21%
Current Stock Chart for FDC LTD (FDCLT)

Related News

No related news articles were found.

fdc ltd (FDCLT) Related Businessweek News

No Related Businessweek News Found

fdc ltd (FDCLT) Details

FDC Limited manufactures and markets various healthcare products in India and internationally. The company primarily offers therapeutics, foods, and bulk drugs. Its therapeutic and food products include anti fungals/dermatological, anti-anaemic, anti-diabetic, anti-diarrhoeals/intestinals/ORS, anti-haemorrhagics, anti-oxidants, anti-spasmodics, antibiotics/antibacterials, antiemetic/antinauseant, antimalarials, antiulcerants, antivirals, calcium supplements, cardio-vascular, central nervous system, ENT and related products, genito urinary system and sex hormones, laxatives, musculo-skeletal system, ophthalmics, orthopaedics, otologicals, pre-probiotic, respiratory and antiallergic, stomatologicals, and vitamins and nutraceuticals. The company’s bulk drug products comprise albuterol sulfate, betaxolol hydrochloride, brimonidine tartrate, bromhexine hydrochloride, cinnarizine, dorzolamide hydrochloride, econazole nitrate, fluconazole, flunarizine dihydrochloride, flurbiprofen, flurbiprofen sodium, ketoconazole, levoalbuterol HCL, levoalbuterol sulfate/tartrate, meclizine HCL, miconazole base, miconazole nitrate, oxbutynin hydrochloride, R-flurbiprofen, salbutamol sulphate, and timolol maleate. Its bulk drugs under development consist of Azelastine HCL, Brinzolamide, Duloxetine HCl, Gemifloxacine Mesylate, Latanoprost, Levo-Betaxolol HCl, Olopatadine HCl, Pregabalin, Rupatadine Fumarate, and Voriconazole. The company also provides anti-diarrhoeals/intestinals/ORS; anti-oxidants; and vitamins and nutraceuticals. FDC Limited was founded in 1936 and is headquartered in Mumbai, India.

Founded in 1936

fdc ltd (FDCLT) Top Compensated Officers

Joint Managing Director and Executive Directo...
Total Annual Compensation: 3.9M
Chairman, Managing Director, Member of Shareh...
Total Annual Compensation: 3.7M
Whole Time Director and Member of Shareholder...
Total Annual Compensation: 3.1M
Whole Time Director
Total Annual Compensation: 3.0M
Compensation as of Fiscal Year 2012.

fdc ltd (FDCLT) Key Developments

FDC Limited Reports Unaudited Standalone Earnings Results for the Third Quarter and Nine Months Ended December 31, 2012

FDC Limited reported unaudited standalone earnings results for the third quarter and nine months ended December 31, 2012. For the quarter, the company reported net sales (net of excise duty) of INR 1,780.056 million compared to INR 1,617.518 million a year ago. Profit from operations before other income and financial costs was INR 380.121 million compared to INR 356.488 million a year ago. Profit from ordinary activities before tax was INR 460.627 million compared to INR 424.023 million a year ago. Net profit was INR 350.686 million or INR 1.92 per basic and diluted share compared to INR 328.962 million or INR 1.79 per basic and diluted share for the same period a year ago. For the nine months, the company reported net sales (net of excise duty) of INR 5,882.889 million compared to INR 5,412.276 million a year ago. Profit from operations before other income and financial costs was INR 1,290.395 million compared to INR 1,165.215 million a year ago. Profit from ordinary activities before tax was INR 1,540.508 million compared to INR 1,317.762 million a year ago. Net profit was INR 1,222.428 million or INR 6.69 per basic and diluted share compared to INR 1,041.218 million or INR 5.66 per basic and diluted share for the same period a year ago.

FDC Limited to Report Q3, 2013 Results on Feb 02, 2013

FDC Limited announced that they will report Q3, 2013 results on Feb 02, 2013

FDC Limited, Board Meeting, Feb 02, 2013

FDC Limited, Board Meeting, Feb 02, 2013. Agenda: To consider and approve the unaudited financial results of the company for the quarter and nine months ended December 31, 2012.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
FDCLT:IN 90.10 INR -1.40

FDCLT Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for FDCLT.
View Industry Companies
 

Industry Analysis

FDCLT

Industry Average

Valuation FDCLT Industry Range
Price/Earnings -- Not Meaningful
Price/Sales -- Not Meaningful
Price/Book -- Not Meaningful
Price/Cash Flow -- Not Meaningful
TEV/Sales -- Not Meaningful
 | 

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact FDC LTD, please visit www.fdcindia.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.